1Anno·

Holding period over 2 years. Underground performance after adjustment for inflation.

Out with the portfolio brake.

28.12

iShares NASDAQ US Biotechnology ETF

Venduto x187 a 5,729 €

1.071,32 €

1,20%

16 Commenti

Cashflow I.@Cashflow_Investor

1Anno

2024 will actually be a year for biotech

•

Visualizza tutti 10 ulteriori risposte

Saschko@WarrenamBuffet

1Anno

I think this was the wrong time to sell it

•

Cekay@CMustermann

1Anno

@Dreamliner Let's see, I'm still checking my sales to see how they went afterwards, would definitely be interesting. But as mentioned above, I have a larger position in BioNTech to continue to hold the biotech/health sector.

••

Dani@Dangu

1Anno

What are you shifting into?

••

ValueWilli@ValueWilli

1Anno

"I Find Your Lack of Faith Disturbing"

••

Cekay@CMustermann

1Anno

@ValueWilli *Würgegeräusche*

•